Anemia (Sickle cell)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Anemia (Sickle cell).php on line 2
Anemia (Sickle cell)

LE WE PMID CA

Anemia (Sickle cell)

2535

Anaemie (Sichelzellanaemie)

Anemia (Sickle cell)

Asthma (BASKET)

Autoantibodies Anti Annexin V

Cadasil

CNS (Stroke BASKET)

Fabry s disease

Hemoglobin F

Hemolysis

Histone deacetylase

Hydroxyurea Hydroxycarbamide

Kidney (Hyperfiltration)

Mitochondria (Mitochondriopathy)

Pulmonary hypertension

Thalassemia

2004 1	Sickle cell disease; a general overview. [15683091] Neth J Med 62(10): 364-74 (2004)
2010 2	Definitions of the phenotypic manifestations of sickle cell disease. [19902523] Am J Hematol 85(1): 6-13 (2010)
2009 3	Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. [19610078] Am J Hematol 84(9): 618-25 (2009)
2005 4	Bone marrow embolism in sickle cell disease: a review. [15849760] Am J Hematol 79(1): 61-7 (2005)
2001 5	Ethical issues in the management of sickle cell pain. [11559953] Am J Hematol 68(2): 127-32 (2001)
2000 6	Renal abnormalities in sickle cell disease. [10706765] Am J Hematol 63(4): 205-11 (2000)
2005 7	Ion transport pathology in the mechanism of sickle cell dehydration. [15618480] Physiol Rev 85(1): 179-200 (2005)
1989 8	Practical management of sickle cell disease. [2696437] Arch Dis Child 64(12): 1748-51 (1989)
1991 9	Vascular occlusion in sickle cell disease: current concepts and unanswered questions. [2009364] Blood 77(7): 1405-14 (1991)
2006 10	Current therapy of sickle cell disease. [16434364] Haematologica 91(1): 7-10 (2006)
2004 11	Established and experimental treatments for sickle cell disease. [15020275] Haematologica 89(3): 348-56 (2004)
2008 12	Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I. [19074079] Hematology Am Soc Hematol Educ Program -(-): 186-92 (2008)
2008 13	Mechanisms of vasculopathy in sickle cell disease and thalassemia. [19074078] Hematology Am Soc Hematol Educ Program -(-): 177-85 (2008)
2006 14	Induction of fetal hemoglobin in the treatment of sickle cell disease. [17124041] Hematology Am Soc Hematol Educ Program -(-): 58-62 (2006)
2006 15	Prevention and management of stroke in sickle cell anemia. [17124040] Hematology Am Soc Hematol Educ Program -(-): 54-7 (2006)
2006 16	Red cell exchange in sickle cell disease. [17124039] Hematology Am Soc Hematol Educ Program -(-): 48-53 (2006)
2005 17	An evidence-based approach to the treatment of adults with sickle cell disease. [16304360] Hematology Am Soc Hematol Educ Program -(-): 58-65 (2005)
2004 18	Sickle cell disease. [15561675] Hematology Am Soc Hematol Educ Program -(-): 35-47 (2004)
2002 19	Novel therapeutic approaches in sickle cell disease. [12446417] Hematology Am Soc Hematol Educ Program -(-): 10-34 (2002)
1999 20	Sickle cell nephropathy. [9890326] J Am Soc Nephrol 10(1): 187-92 (1999)
2007 21	Sickle cell disease: old discoveries, new concepts, and future promise. [17404610] J Clin Invest 117(4): 850-8 (2007)
2002 22	The initiation and progression of sickle cell nephropathy. [12028473] Kidney Int 61(6): 2277-86 (2002)
2000 23	Renal abnormalities in sickle cell disease. [10620181] Kidney Int 57(1): 1-8 (2000)
2008 24	The sickle cell crisis: a dilemma in pain relief. [18315999] Mayo Clin Proc 83(3): 320-3 (2008)
2001 25	Sickle cell hepatopathy. [11343226] Hepatology 33(5): 1021-8 (2001)
1985 26	Sickle cell nephropathy: new insights into its pathophysiology. [3894760] Kidney Int 27(5): 711-7 (1985)
1989 27	Diagnostic imaging of bone and joint abnormalities associated with sickle cell hemoglobinopathies. [2655384] AJR Am J Roentgenol 152(6): 1153-9 (1989)
2007 28	Musculoskeletal manifestations of sickle cell disease. [17620464] Radiographics 27(4): 1005-21 (2007)
1998 29	Sickle cell disease: imaging of cerebrovascular complications. [9457180] Radiology 206(2): 311-21 (1998)
2010 30	Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. [20658592] Am J Hematol 85(8): 611-3 (2010)
2011 31	Asthma in sickle cell disease: implications for treatment. [21490765] Anemia 2011(-): 740235 (2011)
2011 32	Musculoskeletal manifestations of sickle cell anaemia: a pictorial review. [21490766] Anemia 2011(-): 794283 (2011)
2003 33	Managing sickle cell disease. [14615343] BMJ 327(7424): 1151-5 (2003)
2005 34	Genetics of cerebrovascular disorders. [15667040] Mayo Clin Proc 80(1): 122-32 (2005)
2006 35	Vasoocclusion in sickle cell anemia: are platelets really involved? [16794229] Arterioscler Thromb Vasc Biol 26(7): 1415-6 (2006)
2011 36	Asthma in sickle cell disease. [21623460] ScientificWorldJournal 11(-): 1138-52 (2011)
2010 37	Genetic correction of sickle cell anemia and beta-thalassemia: progress and new perspective. [20419277] ScientificWorldJournal 10(-): 644-54 (2010)
2008 38	Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. [19112541] ScientificWorldJournal 8(-): 1295-324 (2008)
2010 39	How I use hydroxyurea to treat young patients with sickle cell anemia. [20223921] Blood 115(26): 5300-11 (2010)
2009 40	Sickle cell disease and stroke. [19797523] Blood 114(25): 5117-25 (2009)
2007 41	Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. [17429008] Blood 110(3): 1043-7 (2007)
2008 42	Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void. [17940207] Blood 111(3): 997-1003 (2008)
2011 43	The rationale for using hydroxycarbamide in the treatment of sickle cell disease. [21454878] Haematologica 96(4): 488-91 (2011)
2010 44	Sickle cell disease: primum non nocere (first do no harm). [20065076] Haematologica 95(1): 4-5 (2010)
2006 45	Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. [16885048] Haematologica 91(8): 1076-83 (2006)
2010 46	Sickle-cell trait: novel clinical significance. [21239829] Hematology Am Soc Hematol Educ Program 2010(-): 418-22 (2010)
2007 47	Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. [18024614] Hematology Am Soc Hematol Educ Program -(-): 84-90 (2007)
2007 48	Hypercoagulability in sickle cell disease: new approaches to an old problem. [18024615] Hematology Am Soc Hematol Educ Program -(-): 91-6 (2007)
2007 49	Current issues in sickle cell pain and its management. [18024616] Hematology Am Soc Hematol Educ Program -(-): 97-105 (2007)
2008 50	Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia. [18617435] Int J Biochem Cell Biol 40(11): 2341-7 (2008)
2003 51	Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway. [12826592] Am J Respir Crit Care Med 168(1): 3-4 (2003)
2007 52	Sickle cell disease-associated pulmonary hypertension: a coat of many colors. [17545455] Am J Respir Crit Care Med 175(12): 1218-9 (2007)
2009 53	Sickle cell disease. [19445751] Clin Evid (Online) 2009(-): - (2009)
2007 54	Sickle cell anemia-associated pulmonary arterial hypertension. [18026658] J Bras Pneumol 33(5): 583-91 (2007)
2010 55	Glomerular hyperfiltration in sickle cell disease. [20299367] Clin J Am Soc Nephrol 5(5): 748-9 (2010)
2007 56	Redox-dependent impairment of vascular function in sickle cell disease. [17964418] Free Radic Biol Med 43(11): 1469-83 (2007)
2011 57	Predictive value of anti-annexin V autoantibodies in the follow-up of vaso-occlusive crisis associated with sickle cell disease. [21657843] Biomark Med 5(3): 363-4 (2011)
2008 58	Hydroxyurea for the treatment of sickle cell disease. [18457478] Evid Rep Technol Assess (Full Rep) -(165): 1-95 (2008)
2010 59	Severe sickle cell disease--pathophysiology and therapy. [19819341] Biol Blood Marrow Transplant 16(1 Suppl): S64-7 (2010)
2011 60	Kidney abnormalities in sickle cell disease. [21959727] Nefrologia 31(5): 591-601 (2011)
2009 61	Hyperhemolysis syndrome in sickle cell disease. [21083443] Expert Rev Hematol 2(2): 111-5 (2009)
2008 62	NIH consensus development statement on hydroxyurea treatment for sickle cell disease. [18309362] NIH Consens State Sci Statements 25(1): 1-30 (2008)
2011 63	Splenic complications of sickle cell anemia and the role of splenectomy. [22084706] ISRN Hematol 2011(-): 864257 (2011)
2007 64	Pulmonary hypertension in sickle cell disease: relevance to children. [17454785] Pediatr Hematol Oncol 24(3): 159-70 (2007)
2010 65	A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease. [20656451] J Pain Symptom Manage 40(3): 416-35 (2010)
PMC 66	Cardiac autonomic dysfunction in sickle cell anaemia and its correlation with QT parameters. [24665151] Niger Med J 54(6):382-5 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Anemia (Sickle cell).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Anemia (Sickle cell).php on line 92